Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cross Country Healthcare's enterprise value is $325 Mil.
Cross Country Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-68 Mil. Therefore, Cross Country Healthcare's EV-to-EBITDA for today is -4.75.
The historical rank and industry rank for Cross Country Healthcare's EV-to-EBITDA or its related term are showing as below:
CCRN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -1010.4 Med: 6.24 Max: 624.3
Current: -4.75
During the past 13 years, the highest EV-to-EBITDA of Cross Country Healthcare was 624.30. The lowest was -1010.40. And the median was 6.24.
CCRN's EV-to-EBITDA is ranked worse than 100% of 506
companies
in the Healthcare Providers & Services industry
Industry Median: 11.1
vs CCRN: -4.75
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Cross Country Healthcare (NAS:CCRN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cross Country Healthcare's PE Ratio (TTM) for today is calculated as:
Cross Country Healthcare's share price for today is $13.255.
Cross Country Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.050.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cross Country Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cross Country Healthcare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cross Country Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cross Country Healthcare's EV-to-EBITDA falls into.
Cross Country Healthcare's current Enterprise Value is $325 Mil.
Cross Country Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-68 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cross Country Healthcare (CCRN) has a EV-to-EBITDA of -4.75 as of Jul. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cross Country Healthcare. According to the industry distribution chart, Cross Country Healthcare ranks #999999 out of 506 companies in the Healthcare Providers & Services industry.
Is Cross Country Healthcare's EV-to-EBITDA too high?
Cross Country Healthcare's current EV-to-EBITDA is -4.75. Based on the distribution chart, Cross Country Healthcare ranks #999999 out of 506 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cross Country Healthcare has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cross Country Healthcare's EV-to-EBITDA compare to SRTA and CYH?
According to the Healthcare Providers & Services industry distribution chart, Cross Country Healthcare ranks #999999 out of 506 companies for EV-to-EBITDA. This places Cross Country Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 11.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.10, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cross Country Healthcare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cross Country Healthcare's current EV-to-EBITDA is -4.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cross Country Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cross Country Healthcare (CCRN) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.44, compared to a current price of $13.26 — trading 27% above its estimated fair value. The current EV-to-EBITDA is -4.75. Cross Country Healthcare's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Cross Country Healthcare (CCRN), the current EV-to-EBITDA is -4.75 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cross Country Healthcare (CCRN) Overvalued in 2026?
Based on GuruFocus' analysis, Cross Country Healthcare stock appears to be overvalued.
The current stock price of $13.26 is trading 27% above its estimated GF Value™ of $10.44.
GuruFocus considers Cross Country Healthcare to be Modestly Overvalued.
Key valuation signals for CCRN:
EV-to-EBITDA: -4.75
GF Value™: $10.44 vs. price of $13.26 (27% above fair value)
No single metric tells the full story. See the CCRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
53GF Score
Get the complete analysis for CCRN
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CCRN has been successfully added to your 
